Formulary Monographs [TAMOXIFEN, 1000]
|
|
TAMOXIFEN
|
|
|
|
|
|
ANTINEOPLASTICS
|
|
|
Adjuvant endocrine therapy of node-positive breast cancer.
|
|
|
Hot flashes, vaginal bleeding, pruritis vulvae, tumor flare, rarely fluid
retention, cataracts, retinopathy , visual disturbances, venous thrombosis. |
|
|
20mg daily as a single or in 2 divided doses. Max. 40mg daily .
|
|
|
|
|
|
Tamoxifen is contraindicated in pregnancy as it may cause fetal harm.
|
|
|
Tamoxifen suppresses lactation. Liscensed product information recommends that it should not be given to lactating women as it is unknown if Tamoxifen appears in breastmilk.
|
|
|
|